Page last updated: 2024-09-02

1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol and MS (Multiple Sclerosis)

1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol has been researched along with MS (Multiple Sclerosis) in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bari, M; Battistini, L; Bernardi, G; Bernardini, S; Centonze, D; De Chiara, V; Fezza, F; Furlan, R; Maccarrone, M; Martino, G; Prosperetti, C; Rossi, S1
Achiron, A; Biegon, A; Lavie, V; Margalit, R; Miron, S1

Other Studies

2 other study(ies) available for 1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol and MS (Multiple Sclerosis)

ArticleYear
The endocannabinoid system is dysregulated in multiple sclerosis and in experimental autoimmune encephalomyelitis.
    Brain : a journal of neurology, 2007, Volume: 130, Issue:Pt 10

    Topics: Acute Disease; Adult; Animals; Arachidonic Acids; Brain; Cannabinoid Receptor Modulators; Corpus Striatum; Disease Models, Animal; Dronabinol; Electrophysiology; Encephalomyelitis, Autoimmune, Experimental; Endocannabinoids; Female; Glycerides; Humans; Lymphocytes; Magnetic Resonance Imaging; Male; Mice; Mice, Inbred C57BL; Multiple Sclerosis; Neuroprotective Agents; Patch-Clamp Techniques; Polyunsaturated Alkamides; Synaptic Transmission; Tissue Culture Techniques

2007
Dexanabinol (HU-211) effect on experimental autoimmune encephalomyelitis: implications for the treatment of acute relapses of multiple sclerosis.
    Journal of neuroimmunology, 2000, Jan-03, Volume: 102, Issue:1

    Topics: Acute Disease; Animals; Brain; Dose-Response Relationship, Drug; Dronabinol; Encephalomyelitis, Autoimmune, Experimental; Female; Injections, Intraperitoneal; Injections, Intravenous; Multiple Sclerosis; Neuroprotective Agents; Rats; Rats, Inbred Lew; Recurrence; Spinal Cord; Time Factors; Treatment Outcome

2000
chemdatabank.com